Tracked deals
5
5 tracked deals across 2019-2026.
Chicago, Illinois, United States
S2G is a multi-stage investment firm focused on venture and growth-stage businesses across food and agriculture, oceans, and energy. The firm provides capital and value-added resources to entrepreneurs and leadership teams pursuing innovative market-based solutions that S2G believes are cheaper, faster or better than traditional alternatives, with flexible capital solutions ranging from seed and venture funding through growth equity to debt and infrastructure financing.
Tracked deals
5
5 tracked deals across 2019-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 divestiture · 1 growth capital
Last 4 years
Supporting Data
3C merged with Datalec Precision Installations to form 3C Datalec, a data-centre infrastructure platform combining liquid cooling, engineering, manufacturing, connectivity and facilities-management capabilities. The combined company is backed by new investment from Longbow Capital, S2G Investments, Apogem Capital and QIC to support international growth and expanded capabilities for AI data centres.
Pyx Health has acquired FarmboxRx after receiving a $47.5 million investment from S2G Investments in strategic partnership with TT Capital Partners. The deal integrates FarmboxRx's customized food-box solutions into Pyx Health's mentor-driven care navigation platform to address food insecurity and strengthen member engagement for health plans, particularly in Medicare and Medicaid populations.
Confluence Genetics, a new agritech company backed by investors led by Expedition Ag Partners and S2G Investments, purchased the business assets of Benson Hill following Delaware bankruptcy court approval. The asset sale will relaunch Benson Hill’s soybean trait business under Confluence Genetics in Creve Coeur, Missouri, retaining an experienced team and focusing on high‑protein soybean genetics, its AI-driven CropOS breeding platform and a speed‑breeding facility.
Prairie Capital VII, Skyline Global Partners and S2G Ventures have partnered with Lief Labs' management and founder Adel Villalobos to recapitalize Lief Labs, a Valencia, California-based dietary supplement formulator and contract manufacturer. The recapitalization provides growth capital and strategic advisory to support investments in technology, raw materials and formulations, supply chain, human capital, production capacity and potential add-on acquisitions while the existing management team and CEO remain in place.
Baird Capital invested in GreenLight Biosciences as part of a $50 million funding round led by S2G Ventures to scale the company's RNA production platform for agricultural and life-science applications. The capital will support expansion of GreenLight's scalable, low-cost RNA manufacturing capabilities and enable entry/expansion into pharmaceutical and crop-protection markets.
Turn tracked acquisition activity into an outreach-ready buyer list.